More than 1,800 people were vaccinated in a campaign that kicked off just five days after the first case was detected.
The outbreak marks the first time the recently-licensed ERVEBO vaccine against Ebola was used in the country. ERVEBO is the same as the compassionate-use vaccine, but as a licensed vaccine, rollout is less cumbersome operationally.
“Stronger disease surveillance, community engagement, targeted vaccination and prompt response are making for more effective Ebola containment in the region,” said Dr Matshidiso Moeti, World Health Organization (WHO) Regional Director for Africa, in a statement.
“During this outbreak, the Democratic Republic of Congo was able to limit widespread infections and save lives. Crucial lessons are being learned and applied with every outbreak experience,” Moeti added.
Swift response comprising key outbreak control measures such as contact tracing, testing, disease surveillance as well as community collaboration efforts helped contain the outbreak within Beni, where the initial case was detected. In support of the country, WHO deployed experts, supplies, and contributed funds to help contain the outbreak.
However, unpredictable and sometimes volatile security in parts of Beni hampered the response in some localities with health workers and other frontline responders unable to access insecure areas to monitor high-risk contacts or administer vaccines.
With the outbreak now declared over, the health authorities are maintaining surveillance and are ready to respond quickly to any flare-ups. It is not unusual for sporadic cases to occur following a major outbreak.
Source: IANS
